E30.1
Precocious puberty
Clinical Classification Guidelines
Inclusion Terms
- Precocious menstruation
Excludes Type 1
- Albright (-McCune) (-Sternberg) syndrome (Q78.1)
- central precocious puberty (E22.8)
- congenital adrenal hyperplasia (E25.0)
- female heterosexual precocious pseudopuberty (E25.-)
- male isosexual precocious pseudopuberty (E25.-)
Medical Intelligence & Overview
Precocious puberty is a condition where a child's body begins to develop and change into that of an adult too early, typically before age 8 in girls and age 9 in boys. It involves early activation of the hormonal processes that lead to puberty, resulting in physical and emotional changes. When this occurs before the usual age, it is classified under ICD-10 code E30.1. This condition can also be associated with early menstruation, known as precocious menstruation, which can impact a child's growth and development if left untreated.
Causes & Symptoms
Clinical Causes: Genetic factors or family history of early puberty Central nervous system abnormalities or tumors Hormonal disorders causing increased levels of pubertal hormones Exposure to external sources of hormones or endocrine-disrupting chemicals In some cases, the cause remains unidentified, termed idiopathic precocious puberty
Key Symptoms: Rapid physical growth compared to peers Development of secondary sexual characteristics such as breast development in girls, testicular enlargement in boys, pubic and underarm hair growth Early menstruation in girls (precocious menstruation) Accelerated bone maturation, which can lead to shorter adult height Possible emotional and behavioral issues due to early developmental changes
Diagnostic & Treatment
Diagnosis Path: Diagnosing precocious puberty involves a comprehensive evaluation including medical history, physical examinations, and laboratory tests. Key diagnostic steps include: - Measuring hormone levels such as luteinizing hormone (LH), follicle-stimulating hormone (FSH), and sex steroids - Brain imaging studies like MRI to identify possible central nervous system causes - Bone age assessment through X-ray to evaluate the maturity of bones - Monitoring the progression of physical changes over time These assessments help determine whether the puberty is central (true precocious puberty) or peripheral (precocious pseudo-puberty), guiding appropriate treatment options.
Treatment Protocols: Treatment strategies aim to halt or slow the early development of puberty to allow normal growth and development. Approaches include: - Hormonal therapies such as gonadotropin-releasing hormone (GnRH) analogs, which suppress premature hormone production - Addressing underlying causes if identifiable, such as tumors or hormonal imbalances - Supportive therapies and counseling to address emotional and psychological effects, if necessary Regular follow-up is essential to monitor growth, hormone levels, and development, ensuring optimal outcomes for the child.
Clinical Advice & FAQs
Billing Guidance
Is E30.1 a billable ICD-10 code?
Yes, E30.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E30.1?
Clinical documentation must specify the nature of Precocious puberty and any associated comorbidities for accurate reporting.
Cite this Clinical Reference